- Home
- EMD vs SIGA Comparison
EMD vs SIGA Comparison
Compare EMD & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EMD
- SIGA
- Stock Information
- Founded
- EMD 2003
- SIGA 1995
- Country
- EMD United States
- SIGA United States
- Employees
- EMD N/A
- SIGA N/A
- Industry
- EMD Finance/Investors Services
- SIGA Biotechnology: Pharmaceutical Preparations
- Sector
- EMD Finance
- SIGA Health Care
- Exchange
- EMD Nasdaq
- SIGA Nasdaq
- Market Cap
- EMD 599.9M
- SIGA 594.3M
- IPO Year
- EMD N/A
- SIGA 1997
- Fundamental
- Price
- EMD $10.31
- SIGA $6.53
- Analyst Decision
- EMD
- SIGA
- Analyst Count
- EMD 0
- SIGA 0
- Target Price
- EMD N/A
- SIGA N/A
- AVG Volume (30 Days)
- EMD 248.5K
- SIGA 352.7K
- Earning Date
- EMD 01-01-0001
- SIGA 11-06-2025
- Dividend Yield
- EMD 10.25%
- SIGA 9.21%
- EPS Growth
- EMD N/A
- SIGA N/A
- EPS
- EMD N/A
- SIGA 1.03
- Revenue
- EMD N/A
- SIGA $172,249,641.00
- Revenue This Year
- EMD N/A
- SIGA N/A
- Revenue Next Year
- EMD N/A
- SIGA $115.06
- P/E Ratio
- EMD N/A
- SIGA $6.32
- Revenue Growth
- EMD N/A
- SIGA N/A
- 52 Week Low
- EMD $7.85
- SIGA $4.95
- 52 Week High
- EMD $9.55
- SIGA $9.62
- Technical
- Relative Strength Index (RSI)
- EMD 42.50
- SIGA 24.95
- Support Level
- EMD $10.32
- SIGA $7.97
- Resistance Level
- EMD $10.48
- SIGA $8.46
- Average True Range (ATR)
- EMD 0.13
- SIGA 0.31
- MACD
- EMD -0.02
- SIGA -0.11
- Stochastic Oscillator
- EMD 6.10
- SIGA 1.72
About EMD Western Asset Emerging Markets Debt Fund Inc
Western Asset Emg Markets Debt Fund Inc is a non-diversified closed-end management, and long term investment company. The primary investment objective of the company is to seek high current income and the secondary objective is to seek capital appreciation.
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.